David Atkins

David Atkins has been named CEO of Congenica, a maker of clinical genomics interpretation software. Atkins will lead Congenica as it looks to expand to the US and Asia, the Cambridge, England-based company said. He previously served as CEO of Synevo, a chain of clinical diagnostic laboratories in Germany and Eastern Europe. With the hiring of Atkins, interim CEO Nick Lench resumes his full-time duties as chief operating officer. Cofounder and former CEO Tom Weaver remains on the Congenica board.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.